ImmuCell Corporation Finite-Lived Intangible Assets, Net
ImmuCell Corporation (ICCC) had Finite-Lived Intangible Assets, Net of $0 as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2026-03-30
- 2025-12-31: Finite-Lived Intangible Assets, Net $0.00.
- 2025-09-30: Finite-Lived Intangible Assets, Net $4.78K.
- 2025-06-30: Finite-Lived Intangible Assets, Net $9.55K.
- 2025-03-31: Finite-Lived Intangible Assets, Net $14.33K.
| Period end | Finite-Lived Intangible Assets, Net |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-30 |
| 2025-09-30 | $4.78K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $9.55K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $14.33K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $19.10K 10-K · filed 2026-03-30 |
| 2024-09-30 | $23.88K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $28.66K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $33.43K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $38.21K 10-K · filed 2025-03-28 |
| 2023-09-30 | $42.98K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $47.76K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $52.54K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $57.31K 10-K · filed 2024-04-01 |
| 2022-09-30 | $62.09K 10-Q · filed 2022-11-21 |
| 2022-06-30 | $66.86K 10-Q/A · filed 2022-11-21 |
| 2022-03-31 | $71.64K 10-Q/A · filed 2022-11-21 |
| 2021-12-31 | $76.42K 10-K · filed 2023-03-29 |
| 2021-09-30 | $81.19K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $85.97K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $90.74K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $95.52K 10-K · filed 2022-03-30 |
| 2020-09-30 | $100.30K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $105.07K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $109.85K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $114.62K 10-K · filed 2021-03-30 |
| 2019-09-30 | $119.40K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $124.18K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $128.95K 10-Q · filed 2019-05-13 |
| 2018-12-31 | $133.73K 10-K · filed 2020-03-27 |
| 2018-09-30 | $138.50K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $143.28K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $148.06K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $152.83K 10-K · filed 2019-03-22 |
| 2017-09-30 | $157.61K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $162.38K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $167.16K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $171.94K 10-K · filed 2018-03-29 |
| 2016-09-30 | $175.73K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $175.60K 10-Q · filed 2016-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |